[Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge]

Ann Dermatol Venereol. 2013 Jun-Jul;140(6-7):474-8. doi: 10.1016/j.annder.2013.04.093. Epub 2013 May 31.
[Article in French]
No abstract available

Publication types

  • Letter

MeSH terms

  • Acne Vulgaris / drug therapy
  • Androgen Antagonists / adverse effects
  • Androgen Antagonists / therapeutic use
  • Contraceptives, Oral, Combined / adverse effects
  • Contraceptives, Oral, Hormonal / adverse effects
  • Cyproterone Acetate* / adverse effects
  • Cyproterone Acetate* / therapeutic use
  • Drug Combinations
  • Drug Utilization / statistics & numerical data
  • Drugs, Generic
  • Ethinyl Estradiol* / adverse effects
  • Ethinyl Estradiol* / therapeutic use
  • Evidence-Based Medicine
  • Female
  • France
  • Government Agencies
  • Humans
  • Risk Assessment
  • Safety-Based Drug Withdrawals / legislation & jurisprudence*
  • Venous Thrombosis / chemically induced
  • Venous Thrombosis / mortality

Substances

  • Androgen Antagonists
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Drug Combinations
  • Drugs, Generic
  • Ethinyl Estradiol
  • Cyproterone Acetate
  • Cyproterone acetate, ethinyl estradiol drug combination